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Background: The EUROSCORE (ES) is widely used to predict outcome after CV surgery. However, it is static & might not reflect on-going changes 
in patient population & surgical results. We hypothesized that the Veterans Affairs (VA) risk score, updated every 6 months, might better predict peri-
operative mortality in valve replacement (AVR) for AS.
Methods: 537 consecutive patients undergoing isolated AVR for severe AS at the Minneapolis VA Medical Center (1997-2008) were stratified 
based on EF &valve gradients. Predicted peri-operative (30 day) mortality was estimated, prospectively, using the ES & VA risk scores and compared 
with actual outcomes.
Results: Table 1 summarizes the data. Overall, observed peri-operative mortality was closer to the estimate by VA risk score (6.74%) vs. the 
EuroScore (15.6%). Euroscore performed worse in the higher risk patients; mortality risk was significantly overestimated by the EuroScore in patients 
with EF≤35 (ES 49.2%, VA 10.5% and actual 7.5%%) and low mean valve gradients (ES 18.9%, VA 7.15% and actual 6.2%). The difference was the 
worst in patients with both low EF and low gradient (see Table).
Conclusion: The regularly updated VA Risk Score is much more accurate than EUROSCORE in predicting peri-operative mortality of AVR for severe 
AS, especially in high risk patients. Euroscore inappropriately classifies these patients as high risk for surgical AVR. The VA risk score might be a 
better prognosticator and may help triaging patients between surgical or percutaneous AVR.
Table 1
EF≤35 MG≤30
EF≤35,
MG>30
MG≤30 (all) MG>30 (all) EF<35 (all) EF>35 (all) All Patients
Total Patients 30 37 113 425 67 470 537
Age(avg) 70.2±6.9 72.6±8.8 69.9±9 70.6±9.7 71.6±8.1 70.3±9.7 70.5±9.6
EF(avg) 27 28 48 55 28 58 54
Gradient(avg) 24 46 24 48 36 44 43
AVA(avg) 0.76 0.60 0.90 0.71 0.68 0.76 0.75
Mortality:
Estimated (Euro)
40.25% 57.66% 18.96% 14.7% 49.2% 10.73% 15.6%
Mortality:
Estimated (VA)
9.25% 12.25% 7.15% 6.63% 10.5% 6.51% 6.74%
Observed Mortality 6.7% 10.8% 6.2% 5.9% 7.5% 5.5% 5.9%
